iBio is an innovator biologics company developing therapeutics and vaccines for the betterment of human and animal health, including a virus-like particle (VLP) -based vaccine against SARS-CoV-2. iBio’s subsidiary, iBio CDMO is a global leader in plant-based manufacturing. It’s FastPharming™ and FastGlycaneering™ platforms provide contract development and manufacturing services via its 130,000 square foot facility in Bryan, Texas. The speed and scalability of FastPharming make it an ideal choice for other innovator companies who want to rapidly produce COVID-19 biologics.

Biotechnology

iBio

iBio's headquarters in New York, NY, United States

Martin Brenner

Brian R. Berquist

Kristi Sarno

Cory Schwartz

Alexander Taguchi

Michael Shassere

Marc Banjak

Felipe Duran

Robert B. Kay

Seymour Flug

General James T. Hill

John D. McKey

Chip Clark

Gary Sender

Eef Schimmelpennink

Alexandra Kropotova

Glenn Chang

Philip K. Russell

The Director Team at iBio consists of key leadership figures overseeing various strategic and operational facets of the company. Each director contributes expertise in their respective domain, such as Quality Assurance, Information Technology, and other critical areas, ensuring alignment with the company's mission to innovate and efficiently produce biologics and vaccines. This team plays a pivotal role in guiding the company’s vision, fostering innovation, and maintaining the highest standards across its extensive manufacturing and development operations.

Director Team

The Scientific and Research Team at iBio is responsible for the innovation and development of new biologics, including therapeutics and vaccines, to enhance human and animal health. This includes the design and execution of pharmacological studies, protein expression, downstream process development, and analytical assessments. Leveraging advanced technologies like machine learning and iBio's proprietary FastPharming™ and FastGlycaneering™ platforms, the team accelerates the production and scalability of biologics, ensuring efficient and rapid response to healthcare challenges such as COVID-19.

Scientific and Research Team

The Finance Team at iBio oversees financial planning, analysis, and reporting to ensure the company’s financial health and regulatory compliance. This includes budgeting, forecasting, and financial modeling to support strategic decision-making. The team also manages corporate accounting, audits, and investor relations to foster transparency and trust among stakeholders.

Finance Team

The Leadership Team at iBio is responsible for guiding the company's strategic direction and ensuring the effective execution of its mission to innovate biologics. Comprising leaders in downstream process development and protein expression sciences, the team collaborates to advance the development of therapeutics and vaccines, leveraging iBio's unique FastPharming™ and FastGlycaneering™ platforms. They play a crucial role in fostering innovation, optimizing manufacturing processes, and driving the company’s growth in the biologics industry.

Leadership Team

��

iBio

Org chart

Board & advisors

Teams

Director Team

Scientific and Research Team

Finance Team

Leadership Team

Offices

��������

iBio

Org chart

Board & advisors

Teams

Director Team

Scientific and Research Team

Finance Team

Leadership Team

Offices

Related companies

��